Global head of the pharmaceutical sector at Miebach Consulting, Martin Eckert, participated at the International Health Seminar held in Lisbon on June 23rd. Mr. Eckert presented the primary findings of the study on trends in the pharmaceutical industry which has been recently developed by the company on a European level.
The objective of the seminar, attended by over 70 participants, was to bring together key players and stakeholders in the value chain of health in Portugal, together for the first time after the publication of Counterfeit Medicines Directive (2011/62 / EU), which sets the guidelines for serialization of medicines and which takes effect in less than three years.
Martin Eckert was one of the speakers of the day and focused his lecture on the results of the pharmaceutical logistics study developed by Miebach Consulting. According to that study, some of the highlights for the pharmaceutical industry are the impact of the latest amendments to the guidelines of the GdP since November 2013 (76% of respondents), the product counterfeit (74%) and two measures to combat it: the implementation of tracking and tracing systems (82%) and serialization (73%). Serialization is one of the issues that generate greater concern, as it is still a pending challenge by the lack of information and the short timeframe announced for implementation.
Eckert spoke about the implications of the implementation of the new EU directive on the supply chains of the pharmaceutical industry, concerning the scope of products, the responsibilities of different key players, the specific requirements of each country, the need to increase visibility across the supply chain and the deliveries in the different channels.
The program of the day included many other conferences by: Guy Villax, President of the RX-360 consortium and CEO of Hovione, Tania Snioch, Director of Health of the global office of GS1, Joan Cahill, Pfizer (representing EPFIA ), Nuno Loureiro, CHLN logistics director, Ana Margarida Freitas, from José de Mello Saúde, Henrique Gil Martins, Chairman of the Board of Directors of the PMSC, Rui Ivo, vice president of Infarmed, etc.
About GS1 Portugal
(CODIPOR - Portuguese Association identification and product coding)
GS1 Portugal - CODIPOR - is the entity that introduced bar codes in Portugal 30 years ago. It is a private, neutral, non-profit organization and also member of the global organization GS1. Founded in 1985 by producers and distributors, it is currently leading the development of standards and best business practices, acting as a facilitator of the value chain.
GS1 Portugal is one of the largest business associations in Portugal, bringing together approximately 7,700 member companies, from raw material producers to distributors, including brand manufacturers, industry associations and technology providers - in order to develop, adopt and implement global standards revolutionize the way we do business.
More information: http://www.gs1pt.org